Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2013, Article ID 420979, 9 pages
http://dx.doi.org/10.1155/2013/420979
Research Article

Role of Renin-Angiotensin System and Oxidative Stress on Vascular Inflammation in Insulin Resistence Model

1Laboratory of Cardiovascular Research, Area of Pathological Physiology, Department of Pathology, School of Medicine, National University of Cuyo, Centro Universitario 5500, Mendoza, Argentina
2Institute of Experimental Medicine and Biology of Cuyo (IMBECU), CONICET, Mendoza, Argentina

Received 22 October 2012; Accepted 5 December 2012

Academic Editor: Agostino Virdis

Copyright © 2013 N. F. Renna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar
  2. A. Tedgui and Z. Mallat, “Cytokines in atherosclerosis: pathogenic and regulatory pathways,” Physiological Reviews, vol. 86, no. 2, pp. 515–581, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Paukku and O. Silvennoinen, “STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5,” Cytokine and Growth Factor Reviews, vol. 15, no. 6, pp. 435–455, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. G. K. Hansson and P. Libby, “The immune response in atherosclerosis: a double-edged sword,” Nature Reviews Immunology, vol. 6, no. 7, pp. 508–519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Brand, S. Page, A. K. Walli, D. Neumeier, and P. A. Baeuerle, “Role of nuclear factor-κB in atherogenesis,” Experimental Physiology, vol. 82, no. 2, pp. 297–304, 1997. View at Google Scholar · View at Scopus
  6. R. Ross, “The pathogenesis of atherosclerosis: a perspective for the 1990s,” Nature, vol. 362, no. 6423, pp. 801–809, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. E. W. Raines and N. Ferri, “Cytokines affecting endothelial and smooth muscle cells in vascular disease,” Journal of Lipid Research, vol. 46, no. 6, pp. 1081–1092, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. Singer, S. Salinthone, K. J. Baker, and W. T. Gerthoffer, “Synthesis of immune modulators by smooth muscles,” BioEssays, vol. 26, no. 6, pp. 646–655, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J. H. Von der Thüsen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen, “Interleukins in atherosclerosis: molecular pathways and therapeutic potential,” Pharmacological Reviews, vol. 55, no. 1, pp. 133–166, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Tedgui and Z. Mallat, “Anti-inflammatory mechanisms in the vascular wall,” Circulation Research, vol. 88, no. 9, pp. 877–887, 2001. View at Google Scholar · View at Scopus
  11. O. A. Carretero and S. Oparil, “Essential hypertension. Part I: definition and etiology,” Circulation, vol. 101, no. 3, pp. 329–335, 2000. View at Google Scholar · View at Scopus
  12. J. F. Keaney, J. M. Gaziano, A. Xu et al., “Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 24, pp. 11880–11884, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. R. F. Furchgott and J. V. Zawadzki, “The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine,” Nature, vol. 288, no. 5789, pp. 373–376, 1980. View at Google Scholar · View at Scopus
  14. L. J. Ignarro, R. E. Byrns, G. M. Buga, and K. S. Wood, “Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical,” Circulation Research, vol. 61, no. 6, pp. 866–879, 1987. View at Google Scholar · View at Scopus
  15. I. Fleming and R. Busse, “Signal transduction of eNOS activation,” Cardiovascular Research, vol. 43, no. 3, pp. 532–541, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. J. B. Michel, O. Feron, K. Sase, P. Prabhakar, and T. Michel, “Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase,” Journal of Biological Chemistry, vol. 272, no. 41, pp. 25907–25912, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Renna, M. A. Vazquez, M. C. Lama, E. S. González, and R. M. Miatello, “Effect of chronic aspirin administration on an experimental model of metabolic syndrome,” Clinical and Experimental Pharmacology and Physiology, vol. 36, no. 2, pp. 162–168, 2009. View at Publisher · View at Google Scholar
  18. N. Risler, C. Castro, M. Cruzado, S. González, and R. Miatello, “Early changes in proteoglycans production by resistance arteries smooth muscle cells of hypertensive rats,” American Journal of Hypertension, vol. 15, no. 5, pp. 416–421, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. M. C. Cruzado, N. R. Risler, R. M. Miatello, G. Yao, E. L. Schiffrin, and R. M. Touyz, “Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation,” American Journal of Hypertension, vol. 18, no. 1, pp. 81–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Siegel and A. L. M. Swislocki, “Effects of antihypertensives on glucose metabolism,” Metabolic Syndrome and Related Disorders, vol. 5, no. 3, pp. 211–219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Renna, N. Lembo C, E. Diez, and R. Miatello, “Vascular repair by endothelial progenitor cells ina an experimental model of metabolic syndrome,” in Handbook on Metabolic Syndrome: Classification, Risk Factors and Health Impact, C. M. L. Garcia and P. A. P. Gonzalez, Eds., Nova Science, New York, NY, USA, 2012. View at Google Scholar
  22. N. F. Renna, E. Diez, C. Lembo, and R. M. Miatello, “Role of COX-2 in vascular inflammation, an experimental model of metabolic syndrome,” Mediators of Inflammation. In press. View at Publisher · View at Google Scholar
  23. E. L. Schiffrin and R. M. Touyz, “From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension,” American Journal of Physiology, vol. 287, no. 2, pp. H435–H446, 2004. View at Publisher · View at Google Scholar · View at Scopus